The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.60
Bid: 7.20
Ask: 8.00
Change: 0.60 (8.57%)
Spread: 0.80 (11.111%)
Open: 6.75
High: 7.60
Low: 6.75
Prev. Close: 7.00
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

31 May 2013 13:30

RNS Number : 0315G
Totally PLC
31 May 2013
 



31 May 2013

 

Totally PLC

 

("Totally", "the Company" or "the Group")

 

Preliminary results for the year ended 31 December 2012

 

Performance highlights

 

* Revenues from continuing operations £1.62m up 86 per cent. (2011: £0.87m)

 

* Gross Profit from continuing operations £0.63m up 31 per cent. (2011: £0.48m)

 

* Operating Loss from continuing operations before tax £(0.55)m (2011: £0.08m)

 

* Total EBITDA from continuing operations £(0.52)m (2011: £0.06m)

 

* Cash (utilised)/generated from operating activities £0.02m (2011: £(0.01)m)

 

* Basic earnings/(loss) per share (0.6)p (2011: (0.2)p per share)

 

* Commencement of sales of digital solutions to healthcare sector

 

* Entry into Shared Decision Making contract with the NHS

 

* Sale of the UK publishing business

 

Chairman's Statement

 

I am pleased to present the preliminary results for the year ended 31 December 2012.

 

2012 marked the transformation of Totally Plc into a serious participant in the Healthcare IT market, maximising the digital expertise within our Totally Communications business to extend and strengthen the capabilities of Totally Health.

 

Key events included the signing of the important Shared Decision Making (SDM) contract with the NHS in January and the sale of our print media business in May. However, more important even than these significant milestones, was the assembly of a strong team of expert professionals and corporate partners.

 

During the latter part of 2012 and early 2013, we raised approximately £1.1 million (net of expenses) of capital for the Company through the placing and exercise of warrants. This fundraising will help us to meet the ongoing challenges of our enhanced contractual responsibilities. As we win new contracts we will seek to ensure that the strength of our balance sheet keeps pace with the strength of our market success. We expect the real benefits of the repositioning of Totally Plc to be reflected in earnings performance from 2014 onwards.

 

Our management team, expertly led by Wendy Lawrence as CEO, is currently submitting proposals for a number of contracts which, if awarded, will enable us to leverage our SDM experience. Wendy was formally appointed to the Board on 2 May 2013. With her previous NHS and private sector experience we are very pleased to have her as our CEO. With healthcare systems throughout the world battling to adapt to serious financial constraints, we believe that the cost savings and enhanced health outcomes we have demonstrated through our programmes to date, will mean our solutions will not only be in demand by Clinical Commissioning Groups (CCGs) and other health organisations in the UK, but also by healthcare providers internationally. We hope to be able to make positive announcements in this regard over the summer months.

 

By providing patients with clear and accurate information to support them through their care pathways, we intend to make an important contribution to society. We believe that by empowering patients with timely and trusted information, Totally's healthcare solutions can play an important part in the therapeutic process. Our success in these endeavours will, I believe, lead to significant increases in value for shareholders and stakeholders alike.

 

Dr. Michael Sinclair

 

Non-Executive Chairman

 

 

Further enquiries:

 

Totally Plc www.totallyplc.com

Wendy Lawrence, CEO 020 7284 9730

 

Allenby Capital Limited

(Nominated Adviser and Joint Broker)

Mark Connelly / Nick Athanas 020 3328 5656

 

 

Optiva Securities Limited

(Joint Broker)

Christian Dennis / Jeremy King 020 3137 1902

 

Chief Executive's Review

 

Totally Plc entered 2012 with two clear aims; to continue its development and growth in the healthcare sector, and to build upon its established reputation as a leading provider of digital technologies. Throughout the year, these two individual Group companies, Totally Health and Totally Communications (with Rise Digital), worked collaboratively to deliver innovative solutions to NHS and private sector organisations, not-for-profit companies and charities.

 

Totally Health

At the end of January 2012, Totally Plc signed its first NHS contract to provide 36 disease-specific Personal Decision Aids (PDAs) and associated Mobile Apps for iPhone and Android handsets. It was also commissioned to provide a CRM database to underpin the Shared Decision Making programme and health coaching for all users of the service. This was an initial one-year contract that ran through to mid-March 2013 for all deliverables. Excellent progress was made during 2012, with the formation of our Medical Advisory Groups, comprising national clinical leaders across specific disease areas. Work continues with NHS England to secure a way forward with their Shared Decision Making Programme

 

2012 also saw us sign of our first NHS contract for the Management of Long Term Conditions, a critical issue and a major priority for the UK's health service. The initial programme has seen us begin work with a group of COPD (Chronic Obstructive Pulmonary Disease) patients, to provide them with telecare (via another supplier) together with Health Coaching services from Totally Health. Early results from this programme are very positive. Evidence shows that the initiative has not only yielded significant cost-savings for the CCG, but it has also had a tremendously positive impact on the health outcomes of the patients involved. Unplanned/emergency admissions to hospital have reduced significantly for this group of patients and their condition has been much better managed, even through the winter months, which are traditionally when COPD patients struggle most.

 

Totally Communications

Totally Communications delivered services to more than 50 clients, many of them with multiple contracts for diverse services.

 

Key highlights include:

 

NHS Shared Decision Making Programme

o 36 Mobile Apps for both iPhone and Android handsets

o Shared decision making application and associated services

o Interactive Website for all Personal Decision Aids (36 in total for 2012)

o SANDY CRM system

 

Health Foundation

o Website redesign

o Design and delivery of mobile website

o Research scan database integration

o Website build for self-management support resource centre

o Website build for Shared Decision Making resource centre

o Email marketing services integration

 

 

 

 

United Synagogue

o Update to membership system to integrate child / teen membership services

o Development of a front end, self-service portal for adult, child / teen members

o Development of back-end events / trip management system, fully integrated reporting and communications tools to service adult and child / teen members

 

Operations

 

2012 was also about building capacity and extending capability. Throughout the year, we continued to expand our team of experts to support sustainable growth across the Group and to ensure we consistently provide the optimal team to deliver a top quality offering to the markets in which we operate.

 

We have strengthened our management teams:

o Andy Margolis is now Chief Operating Officer for Totally Plc

o Ben Gritz is Managing Director for Totally Communications

o Don Baladasan is our Finance Director

 

Our clinical team continues to grow in strength as new service models are planned and developed.

 

Our Bids team has gone from strength to strength and processes are in place to ensure we are able to respond to all queries efficiently and effectively. This work has continued into 2013.

 

2012 was certainly an exciting year for all concerned - but I believe that this was only the beginning of what promises to be an exciting phase of growth and development for the Company.

 

Financial Review

 

The Company's strategic repositioning translated into revenue growth of 86% in 2012 to £1.62m (2011:£0.87m). Totally Health contributed £0.77m of which £0.71m related to delivery of the NHS SDM contract and £0.06m related to the pilot COPD health coaching contract for NHS Leicester. Totally Communications contributed £0.85m.

 

The operating loss for the year was £(0.56)m and the contribution split across the Group was Totally Communications £0.03m, Totally Health £(0.26)m and Totally Plc £(0.33)m. The losses in Totally Health reflected the infrastructure improvement costs including ISO accreditation and business development. These costs were incurred to strengthen the Group's ability to win and deliver further contracts.

 

Group operating cash generated during the year was £0.02m this included the covering of all Plc costs. In addition the Group undertook a warrant conversion funding round which generated net cash of £0.5m in December 2012. The second part of this funding generated a further £0.5m in January 2013. The funding proceeds were used to finance the costs incurred in repositioning the Company and to provide working capital. The current cash balance is approximately £0.3m and there are no bank borrowings.

 

As referred to above we are pleased that there are a number of significant new business opportunities under negotiation, certain of which we hope to be able to announce in the near term. The recent transition from Primary Care Trusts (PCTs) to CCGs in April has resulted in considerable internal reorganisation within the NHS. In particular for Totally this has affected the management of budgets and the contract decision making process with the new NHS bodies.

 

Totally is confident that, as the new CCGs and other NHS bodies bed down, the award of contracts will accelerate in the second half of 2013. In the short term this has resulted in a reduction in expected revenues for the Group in the current financial year but the Board is confident that it has sufficient working capital at present to operate the business going forward should the expected contracts and contracted revenue crystallise in line with internal projections. Having said that the Board is exploring options to strengthen the Company's balance sheet over the next few months, one of which may be through the issue of new equity to ensure that the Company has adequate resources to implement its business plan in full and fully capitalise on the exciting opportunities that the Company has ahead of it.

 

I would like to thank everyone involved with the delivery of every aspect of every area of the Company and for their dedication and commitment during 2012.

 

 

Wendy Lawrence

Chief Executive Officer

 

 

 

Consolidated Income Statement for the year ended 31 December 2012

 

 

 

 

 

2012

£000

 

 

2011

£000

Continuing operations:

 

 

 

 

 

Revenue

 

 

1,619

 

871

 

 

 

 

 

 

Cost of sales

 

 

(986)

 

(395)

 

 

 

 

 

 

Gross profit

 

 

633

 

476

 

 

 

 

 

 

Administrative expenses

 

 

(1,150)

 

(539)

 

 

 

 

 

 

Loss before interest, tax, depreciation and amortisation

 

 

(517)

 

(63)

 

 

 

 

 

 

Depreciation

 

 

(13)

 

(4)

Amortisation

 

 

(25)

 

(18)

 

 

 

 

 

 

Operating loss

 

 

(555)

 

(85)

 

Share issue costs

 

 

 

(54)

 

 

-

Finance costs

 

 

(38)

 

(25)

 

 

 

 

 

 

Loss before taxation

 

 

(647)

 

(110)

 

 

 

 

 

 

 Tax

 

 

-

 

-

 

 

 

 

 

 

Loss for the year from continuing operations

 

 

(647)

 

(110)

 

 

 

 

 

 

Profit/(loss) for the year from discontinued operations

 

 

59

 

(39)

 

 

 

 

 

 

Loss for the year attributable to the equity shareholders of the parent company

 

 

(588)

 

(149)

 

 

 

 

Earnings/(loss) per share

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

 

 

Continuing operations

 

 

(0.63)

 

(0.12)

Discontinued operations

 

 

0.06

 

(0.04)

Total

 

 

(0.57)

 

(0.16)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statement of changes in equity for the year ended 31 December 2012

 

 

 

 

 

 

 

 

 

Share

capital

 

Share

premium

account

 

Profit

and loss

account

 

Equity share-

holders'

deficit

 

 

£000

 

£000

 

£000

 

£000

 

 

 

 

 

 

 

 

 

 

At 1 January 2011

1,124

 

3,353

 

(4,798)

 

(321)

 

 

 

 

 

 

 

 

 

Total comprehensive loss for the year

-

 

-

 

(149)

 

(149)

 

 

 

 

 

 

 

 

 

Credit on issue of warrants

-

 

-

 

14

 

14

 

 

 

 

 

 

 

 

 

At 1 January 2012

1,124

 

3,353

 

(4,933)

 

(456)

 

 

 

 

 

 

 

 

 

Total comprehensive loss for the year

-

 

-

 

(534)

 

(534)

 

 

 

 

 

 

 

 

 

Issue of share capital

569

 

-

 

(54)

 

515

 

 

 

 

 

 

 

 

 

Credit on issue of warrants

-

 

-

 

13

 

13

 

 

 

 

 

At 31 December 2012

1,693

 

3,353

 

(5,508)

 

(462)

 

 

 

Consolidated statement of financial position as at 31 December 2012

 

 

 

2012

 

2011

 

 

 

£000

£000

£000

£000

 

 

 

 

 

 

Non current assets

 

 

 

 

 

Intangible fixed assets

 

11

 

29

 

Property, plant and equipment

 

24

 

23

 

 

 

 

35

 

52

 

 

 

 

 

 

Current assets

 

 

 

 

 

Amounts recoverable on contracts

 

154

 

 

 

Trade and other receivables

 

363

 

606

 

Cash and cash equivalents

 

50

 

134

 

 

 

 

 

 

 

 

 

 

567

 

740

 

 

 

602

 

792

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

Trade and other payables

 

 

(1,064)

 

(658)

Financial liabilities

 

 

-

 

(590)

 

 

 

(1,064)

 

(1,248)

 

 

 

 

 

 

Net current liabilities

 

 

(497)

 

(508)

 

 

 

 

 

 

 

 

 

 

 

 

Net liabilities

 

 

(462)

 

(456)

 

 

 

 

 

 

Shareholders' equity

 

 

 

 

 

 

 

 

 

 

 

Called up share capital

 

 

1,693

 

1,124

Share premium account

 

 

3,353

 

3,353

Retained earnings

 

 

(5,508)

 

(4,933)

 

 

 

 

 

 

Equity shareholders' deficit

 

 

(462)

 

(456)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated cash flow statement for the year ended 31 December 2012

 

 

 

2012

2011

 

 

 

£000

 

£000

Cash flows from operating activities

 

 

 

 

 

Operating loss

 

 

(555)

 

(85)

Option and warrants charge

 

 

13

 

14

Amortisation and depreciation

 

 

35

 

22

 

 

 

 

 

 

Movement in amounts recoverable on contracts

 

 

(154)

 

-

Movement in trade and other receivables

 

 

(211)

 

5

Movement in trade and other payables

 

 

965

 

74

 

 

 

 

 

 

Cash generated from continuing operations

 

 

93

 

30

 

Cash utilised from discontinued operations

 

 

(70)

 

(44)

 

Net cash flows from operating activities

 

 

23

 

(14)

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

Purchase of intangible fixed assets

 

 

(9)

 

-

Purchase of property, plant and equipment

 

 

(28)

 

(15)

Cash received from disposal of subsidiary net of costs

 

 

43

 

-

 

 

 

 

 

 

Net cash flows from investing activities

 

 

6

 

(15)

 

 

 

 

 

 

Cash inflow/(outflow) before financing

 

 

29

 

(29)

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Interest paid

 

 

(38)

 

(25)

Issue of share capital, net

 

 

515

 

-

 

 

 

 

 

 

Net cash flows from financing activities

 

 

477

 

(25)

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

 

506

 

(54)

Cash and cash equivalents at beginning of year

 

 

(456)

 

(402)

 

 

 

 

 

 

Cash and cash equivalents at end of year

 

 

50

 

(456)

 

 

 

 

 

 

Cash and cash equivalents comprise:-

 

 

 

 

 

Cash at bank

 

 

50

 

134

Bank overdrafts

 

 

-

 

(590)

 

 

 

50

 

(456)

 

 

General information

Totally Plc is a public limited company incorporated in the United Kingdom under the Companies Act 2006 (registration number 3870101). The Company is domiciled in the United Kingdom and its registered address is Unit 800 Highgate Studios, 53-79 Highgate Road, London NW5 1TL. The Company's Ordinary Shares are traded on the AIM Market of the London Stock Exchange ("AIM").

 

The Group's principal activities have been the provision of software development and digital marketing services, provided by the subsidiary Totally Communication. At the beginning of 2012 the group established a new subsidiary, Totally health, which provides digital solutions to the healthcare sector. The group had activities of niche community media activities until the Jewish News was sold in May 2012. The Company's principal activity is to act as a holding company for its subsidiaries.

Segmental analysis

 

The Group considers there to be the following reportable operating segments organised around goods and services:

 

Digital marketing - consists of Totally Communications' activities which have three main service sectors being website and software design & development, consultancy & systems integration and online marketing.

 

Digital solutions to the healthcare sector - consists of Totally Health's activities.

 

Head office costs - these are central costs that are offset by internal cost recoveries from the Group's operating businesses and by sundry income which is not attributable to any of the Group's operations.

 

The UK publishing operation was discontinued in the current year.

 

Analysis by business segment 2012:

 

Digital marketing

Digital solutions for healthcare

Head Office

Intra-group adjustments

Total continued operations

Discontinued operations

Total

£000

£000

£000

£000

£000

£000

£000

Revenue

988

769

-

(138)

1,619

550

2,169

EBITDA

62

(253)

(326)

-

(517)

(12)

(529)

Depreciation

(4)

(8)

(1)

-

(13)

(3)

(16)

Amortisation

(25)

-

-

-

(25)

-

(25)

Operating (loss) / profit

33

(261)

(327)

-

(555)

(15)

(570)

Profit on disposal of UK publishing

-

-

-

-

-

74

74

Share issues costs

-

-

(54)

-

(54)

-

(54)

Finance costs

(1)

-

(37)

-

(38)

-

(38)

(Loss)/profit before tax

32

(261)

(418)

-

(647)

59

(588)

Income tax

-

-

-

-

-

-

-

(Loss)/profit after tax

32

(261)

(418)

-

(647)

59

(588)

 

Analysis by business segment 2011:

 

Digital marketing

Head Office

Total continued operations

Discontinued operations

Total

£000

£000

£000

£000

£000

Revenue

871

-

871

974

1,845

EBITDA

152

(215)

(63)

(43)

(106)

Depreciation

(4)

-

(4)

(5)

(9)

Amortisation

(18)

-

(18)

-

(18)

Operating (loss)/profit

130

(215)

(85)

(48)

(133)

Finance costs

-

(25)

(25)

-

(25)

(Loss)/profit before tax

130

(240)

(110)

(48)

(158)

Income tax

-

-

-

9

9

(Loss)/profit after tax

130

(240)

(110)

(39)

(149)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR LLFFFEFILVIV
Date   Source Headline
7th May 20247:00 amRNSTrading Update
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.